Member Exclusive

Modified stem cells used to produce missing blood clotting factors

Engineered allogeneic stem cells, which were shielded from the immune system by biomaterial encapsulation, have been used to treat hemophilia by producing recombinant human hemophilia factors.

Go to the profile of RegMedNet
May 01, 2019

Please sign in or register for FREE

No comments yet.